共 20 条
[1]
The renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure is not dependent on enhanced kinin activity. Nabokov A,Amann K,Gassmann P,et al. Nephrology Dialysis Transplantation . 1998
[2]
Activation of a local tissue angiotensin system in podocytes by mechanical strain. Durvasula RV,Petermann AT,Hiromura K,et al. Kidney International . 2004
[3]
Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. Graciano ML,Cavaglieri Rde C,Delle H,et al. Journal of the American Society of Nephrology . 2004
[4]
Proinflammatory actions of angiotensin II. Ruiz-Ortega M,Lorenzo O,Suzuki Y,et al. Current Opinion in Nephrology and Hypertension . 2001
[5]
Interactions of transforming growth factor-[beta]and angiotensin II in renal fibrosis. Border WA,Noble NA. Journal of Hypertension . 1998
[6]
Renoprotective effect of triple therapy with low-dose angiotensin receptor blocker, low-dose diuretic and Ca- antagonist in hypertensive type 2 diabetic patients with overt nephropathy. Kuriyama S,Tomonari H,Ohtsuka Y,et al. Nippon Jinzo Gakkai Shi . 2003
[7]
ACE inhibition versus angiotensin receptor blockade: which is better for renal and cardiovascular protection. Laverman GD,Remuzzi G,Ruggenenti P. Journal of the American Society of Nephrology . 2004
[8]
Additive effects of enalapril and losartan in(mREN-2)27 transgenic rats. Richer C,Bruneval P,Menard J. Journal of Hypertension . 1998
[9]
Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Peters H,Border WA,Noble NA. Kidney International . 1998
[10]
Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria Study Group.Kidney function during and after withdrawal of long- term irbesartan treatment in patients with type 2 diabetes and microalbuminuria. Andersen S,Brochner-Mortensen J,Parving HH. Diabetes Care . 2003